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Introduction
The artificial sweetener aspartame is a phenylalanine-contaiing dipeptide (aspartylphenylalanine-methylester).
Because it is about 200 times sweeter than sugar (1), normally individuals are not likely to consume it in sizeable amounts, but some might conceivably ingest large amounts in a relatively short period (2). One potentially significant consequence of such megadosing could be suppression of the rise in brain-tryptophan level and serotonin synthesis that normally accompanies the ingestion of a carbohydrate meal (2). Such an effect is predicted from the known competition among the large neutral amino acids (phenylalanine, tyrosine, tryptophan, leucine, isoleucine, valine) for transport across the blood-brain barrier.
That is, when a carbohydrate meal is consumed by a fasting rat, the secretion of insulin lowers considerably the blood levels of the branched-chain amino acids, those of phenylalanine and tyrosine modestly, but does not modify (and sometimes raises) blood-tryptophan levels (3). As a con- 
Methods

Initial studies
In initial studies, we obtained a time-course of the effects of ingesting aspartame (APM) with a high-carbohydrate, protein-free meal on serum and brain levels of tyrosine and phenylalanine to ascertain the optimal time for doseresponse studies.
Groups of eight food-deprived adult male SpragueDawley rats (COBS, Charles River Breeding Laboratories, Wilmington, MA) weighing 343 ± lOg each consumed a high-carbohydrate, protein-free meal containing aspartame (64 g/kg diet,dry weight). They were killed at 0,30,60, 120, or 240 mm thereafter. Animals killed after 30 mm each consumed 3.5 gfood (dry weight), giving an aspartame dose of650 mg/kg body weight; after60 mm, 4.3 g,giving an aspartame dose of 800 mg/kg body weight; after 120 mm, 5.5 g,giving an aspartame dose of 1025 mg/kg body weight; and after240 mm, 6.5 g,giving an aspartame dose of 1215 mg/kg body weight.
As indicated in Table  1 , ingestion of this meal containing 64 g/kg APM (dry weight) caused serumphenylalanine concentrations to rise monotonically to a peak 2 h afterfood presentation.
Brain-phenylalanine levels also rose during the first 2 h and then plateaued.
Serumtyrosine levelsincreased during the 2-h period after food presentation and then plateaued, while brain-tyrosine levels were higher at 4 h than at 2 h (though the change between 2 h and 4 h is about one-third that during the first 2 h). Serum-tyrosine:LNAA and serum-phenylalanine: LNAA ratios (predictors of the competitive uptake into brain of tyrosine and phenylalanine, respectively, and analogous to the tryptophan:LNAA ratio [see ref 3]), also rose during the first 2 h after food presentation.
The tyrosine ratio showed a small, further increment at 4 h, while the phenylalanine ratio showed a small decline during this period. On the basis of these results, principally that the major increments in serum-and brain-tyrosine and phenylalanine occurred during the first 2 h after meal presentation, we selected the 2-h timepoint for subsequent, doseresponse experiments. began at 0900 h) or given free access for this period to one ofthe diets described below. After 90 mm, each rat received an intraperitoneal injection of m-hydroxybenzyl-hydrazine (100 mg/kginwatervehicle).
Dose
Thisdrug, NSD-l015, (Sigma Chemical Co, St Louis, MO) is an inhibitor of aromatic L-amino acid decarboxylase; it blocks 5-hydroxytryptophan decarboxylation in serotonin-synthesizing neurons. (Following its injection, 5-hydroxytryptophan levels increase linearly for 30-45 mm. As a result, quantitation of 5HTP levels during this time period allows an estimation of the in vivo rate of tryptophan hydroxylation [12] .) Thirty minutes afterNSD-l015 injection (7, 12), animals were sacrificed by decapitation.
Trunk-blood samples were collected, placed in an ice bath, and centrifuged at the end of the experiment to obtain serum. Serum samples were then frozen. The brains were collected, the cerebelli removed, the remainder of the brains bisected midsagitally, and then allhalf.brainand cerebellumsamples were frozen on dry ice within 2 mm of sacrifice. suppressed the carbohydrate-induced increments in brain-tryptophan levels and 5HTP accumulation.
Stomach
In addition, as shown in Table  4 Data are presented as the means ± SEM. In experiment I, rats weighed 244 ± 3 g and ingested 5.5 g of the APM-containing food (dry weight), givingan APM dose of 1440 mg/kg body weight. In experiment II, one group of rats ingested 5.5 5/rat of a 16-g/kg diet (dry weight) (animal weight = 280±9 g APM dose = 315 mg/kg body weight); another group ingested 5 5/rat of a 32-5/kg APM diet (animal weight = 302 ± 6 g APM dose = 530 mg/kg body weight). Table 2 and discussion below). If the results at 530 mg/kg body weight are conservatively taken as definitive, the threshold dose for an effect of aspar- (Table 2 ) as in those consuming the 530 mg/kg dose. For example, the reduction in serum leucine in the experiment in Table 2 was from 123 ± 9 to 56 ± 6 nmol/ ml (54% reduction); in the experiment in Table  4 , it was from 142 ± 13 to 106 ± 5 nmol/ml (25% reduction).
Similar differences between the two studies were noted for isoleucine and valine (data not shown). Hence, perhaps variability in the response of serum branchedchain amino acid levels to insulin secretion, or in the degree of insulin secretion in response to carbohydrate ingestion, produced this difference in the ability of aspartame to suppress the carbohydrate-induced rise in brain- Figure  1 and Tables 1-4 ). This phenomenon explains why, for example, doses of 1440 and
